VIP peptides are research-only compounds studied for gut, immune, and neuro effects. Learn what VIP peptide does, dosage research, and safety facts.
VIP peptides are research compounds based on vasoactive intestinal peptide, a 28-amino-acid signaling molecule the human body produces in the nervous system, gut, and immune tissue. No VIP peptide is FDA-approved for human use in the United States, and products sold online are labeled for laboratory research only. Most available evidence comes from cell studies, animal models, and a small number of clinical trials using synthetic forms such as aviptadil.
What Is a VIP Peptide?
Vasoactive intestinal peptide belongs to the secretin–glucagon family of signaling peptides. It is released by neurons in the central and peripheral nervous systems and by immune cells, and it acts mainly through two receptors called VPAC1 and VPAC2.
- Size: 28 amino acids, making it one of the shorter peptide hormones.
- Half-life: very short in blood plasma, often measured in one to two minutes.
- Clearance: broken down quickly by enzymes such as DPP-IV and neutral endopeptidase.
- Analogs: synthetic versions and receptor-selective analogs were created to last longer in laboratory work.
Because natural VIP disappears so quickly, researchers rarely study the native peptide on its own. They usually rely on stabilized analogs or modified delivery routes to keep receptor activity measurable.
How Does a VIP Peptide Work in the Body?
VIP binds VPAC receptors on the surface of cells, raising cyclic AMP inside the cell and setting off a chain of downstream signals. In blood vessels, that signal relaxes smooth muscle and increases blood flow. In the gut, it drives secretion and motility. In immune tissue, it tends to shift cytokine balance toward a less inflammatory profile.
That broad activity is exactly what makes VIP hard to describe as one thing. A single peptide can influence breathing, digestion, heart rate, and immune signaling at the same time, and the effects depend on dose, route, and tissue.
It also helps to separate VIP from growth-hormone research. Unlike hgh peptides, VIP is not primarily studied for growth hormone release or muscle building, and it should not be marketed as a performance or bodybuilding compound.
What Is VIP Peptide Research Focused On?
Published work clusters around a handful of areas, and most of it is preclinical.
- Lung injury and ARDS: intravenous and inhaled aviptadil have been tested in hospital-based trials.
- Pulmonary hypertension and sarcoidosis: small studies have looked at vasodilation and immune effects.
- Gut function: motility, secretion, and inflammatory bowel conditions in animal models.
- Brain and circadian rhythm: VIP helps set the timing of the body's internal clock in rodent studies.
- Immune regulation: T-cell and macrophage signaling in cell culture and animal work.
- Oncology: early laboratory work on tumor immunology exists, and it is sometimes confused with the market for anti cancer peptides for sale, but VIP is not an approved cancer treatment.
| Compound | Form | Main research interest | Regulatory status |
|---|---|---|---|
| Vasoactive intestinal peptide (VIP) | Native 28-amino-acid peptide | Receptor signaling, gut and immune studies | Research use only |
| Aviptadil | Synthetic VIP | ARDS, sarcoidosis, pulmonary hypertension | Not FDA-approved for general use |
| Ro 25-1553 | VPAC2-selective analog | Airway and smooth muscle research | Research use only |
| PACAP | Related peptide in the same family | Neuroprotection and migraine research | Research use only |
None of these are approved consumer products in the United States, so a “VIP peptide” listing on a vendor website should be read as a research chemical label rather than a treatment.
Dosage in Published Research: What the Studies Report
There is no standard human dose for VIP. Every published protocol sets its own amount, and that amount is tied to a specific route, a specific analog, and a specific medical setting. Animal doses cannot be converted into human doses.
The table below shows how research routes differ. It is not dosing guidance.
| Route studied | Form used | Research context | Standard human dose? |
|---|---|---|---|
| Intravenous infusion | Aviptadil | ARDS, sarcoidosis, and pulmonary hypertension trials | No; set per study protocol |
| Inhaled | Aviptadil | Lung injury and pulmonary hypertension research | No |
| Intranasal | Synthetic VIP peptide | Small human studies of sleep, mood, and immune markers | No |
| Subcutaneous or intraperitoneal | Research-grade VIP | Animal and cell models | No |
Anyone looking for a vip peptide dosage chart online should be cautious. Dose information that arrives without a study citation, a route, and a formulation is not useful, and it may not be safe.
VIP Peptide Side Effects and Safety
Reported vip peptide side effects in trials and case reports include flushing, low blood pressure, rapid heart rate, headache, and dizziness, all of which fit with strong vasodilation. Some people also report gastrointestinal upset such as cramping or diarrhea.
Because VIP widens blood vessels and lowers blood pressure, the risk profile matters most for people who already take blood pressure medication, have heart conditions, or are pregnant or breastfeeding. The inhaled and intravenous forms used in trials were given under clinical supervision with monitoring.
VIP peptides are not FDA-approved for human use, and self-dosing with research-grade peptide carries serious risks, including contamination, incorrect dosing, and unpredictable reactions.
Talk with a licensed healthcare professional before using any peptide product, and never replace prescribed treatment with an unregulated compound.
Handling, Storage, and Lab Practice
Research-grade VIP peptides usually ship as lyophilized powder and must be reconstituted before laboratory use. If that is part of your work, review how to mix bac water with peptides and follow your institution's written protocol for sterile technique and storage.
Lyophilized peptide is generally stored frozen and protected from light, while reconstituted solutions are typically kept cold and used within the window the manufacturer specifies. Freeze–thaw cycles degrade peptides, so aliquot before freezing.
Label every vial clearly, log the date and lot number, and keep research compounds away from household areas and children.
Frequently Asked Questions
Is VIP peptide safe for humans?
No VIP peptide is FDA-approved for human use in the United States. Clinical trials have used synthetic forms such as aviptadil under medical supervision, where flushing, low blood pressure, and rapid heart rate were reported. Research-grade products sold online are not manufactured to medicine standards, so their purity and actual dose are not guaranteed.
Where can you buy VIP peptides?
VIP peptides are sold by laboratory supply companies as research chemicals, not as consumer drugs. There is no FDA-approved VIP product available at a pharmacy for general use. Check for third-party purity testing and a certificate of analysis, and understand that vendors cannot legally sell these compounds for human consumption.
Is there a standard VIP peptide dosage?
No. Published studies each define their own dose based on the route, the form of VIP, and the condition being studied. Doses used in animal research cannot be converted to human doses, and online dosage charts usually lack citations and safety data.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.